Montefiori, L. E., Iacobucci, I., Gao, Q., Moore, J., Wright, W. C., Wei, H., Baviskar, P., Sona, S., Jin, H., Budhraja, A., Lott, J., Tatarata, Q. Z., Cheng, Z., Khan, T., Wagner, E. A. B., Johnson, M., Mehr, C. M., Freeman, B., Janke, L., Haferlach, T., Geeleher, P., Mead, P. E., Konopleva, M., Opferman, J. T., Mullighan, C. G. (2025). Venetoclax plus gilteritinib is effective in preclinical models of
                    <i>FLT3</i>
                    -mutant BCL11B-a lineage-ambiguous leukemia. Blood. https://doi.org/10.1182/blood.2025028985